Four additional cases of Burkholderia gladioli infection with microbiolgical correlates and review

Clinical Infectious Diseases

Volumn 25, Issue 4, 1997, Pages 838-842

  Graves, Margot ^b   Robin, Tom ^b   Chipman, Anna Marie ^b   Wong, Jane ^b   Khashe, Shideh ^b   Michael Janda, J ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LOMEFLOXACIN; NAFCILLIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BURKHOLDERIA; CASE REPORT; CHILD; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030761554     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515551     Document Type: Article

References (14)

1. Yabuuchi E, Kosako Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992;36: 1251-75.
2. Yabuuchi E, Kosako Y, Yano I, Hotta H, Nishiuchi Y. Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb, nov., Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov. Microbiol Immunol 1995;39: 897-904.
3. AL. In: Krieg NR, Holt JG, eds. Bergey's manual of systematic bacteriology. Vol. 1. Baltimore: Williams & Wilkins, 1984:141-99.
4. Mortensen JE, Schidlow DV, Stahl EM. Pseudomonas gladioli (marginata) isolated from a patient with cystic fibrosis. Clin Microbiol Newsl 1988;10:29-30.
5. Christenson JC, Welch DF, Mukwaya G, Muszynski MJ, Weaver RE, Brenner DJ. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol 1989;27: 270-3.
6. Ross JP, Holland SM, Gill VJ, DeCarlo ES, Gallin JI. Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin Infect Dis 1995;21: 1291-3.
7. Khan SU, Gordon SM, Stillwell PC, Kirby TJ, Arroliga AC. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation [letter]. Pediatr Infect Dis J 1996;15:637-9.
8. Weyant RS, Moss CW, Weaver RE, et al. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. 2nd ed. Baltimore: Williams & Wilkins, 1996:482-3, 692-3.
9. Paula SJ, Duffey PS, Abbott SL, et al. Surface properties of autoagglutinating mesophilic aeromonads. Infect Immun 1988;56:2658-65.
10. Wong JD, Miller MA, Janda JM. Surface properties and ultrastructure of Edwardsiella species. J Clin Microbiol 1989;27:1797-801.
11. Janda JM, Abbott SL. Expression of an iron-regulated hemolysin by Edwardsiella larda. FEMS Microbiol Lett 1993;111:275-80.
12. Rajkovic IA, Williams R. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci 1985;68:247-53.
13. Moss RB, Lewiston NJ. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis. Am Rev Respir Dis 1980; 121:23-9.
14. Thomassen MJ, Demko CA. Serum bactericidal effect on Pseudomonas aeniginosa isolates from cystic fibrosis patients. Infect Immun 1981; 33:512-8.